Dr. Lecia Sequist describes the state of the art and her view of current best practices on molecular testing for advanced non-small cell lung cancer.
[powerpress]
Logo
You are here
Dr. Lecia Sequist on Molecular Marker Testing in Advanced NSCLC in 2013: What, Who, and When?
Related Content
Article
2021 LIVE ONLINE
Targeted Therapies Patient Forum
July 17, 2021 10:00 AM Eastern
Video
We continue to present final videos from this highly anticipated annual event, the 2020 Targeted Therapies Patient Forum.
This event's live-online presentations and discussions were launched by our Event Chair, Luis E. Raez, MD FACP FCCP, Member of the GRACE Board of Directors, President of the Florida Society of Clinical Oncology (FLASCO), and Chief Scientific Officer & Medical Director at Memorial Cancer Institute.
Video
We continue to present final videos from this highly anticipated annual event, the 2020 Targeted Therapies Patient Forum.
This year's live-online presentations and discussions were launched by our Event Chair, Luis E. Raez, MD FACP FCCP, Member of the GRACE Board of Directors, President of the Florida Society of Clinical Oncology (FLASCO), and Chief Scientific Officer & Medical Director at Memorial Cancer Institute.
Community Forum
Last Reply:
Hi Shannon, I'm so sorry to hear about the extensive problems you've endured. I wish we could help but we are prepared to answer questions about a diagnosed cancer and not...
Last Reply:
Прошу подсказать? Не могу создать первое сообщение. Спасибо.
Last Reply:
Thanks so much for the quick response. Hearing the line "large mass in your scapula with probable neoplastic properties" threw me through a loop. I really expected bursitis. I'm hopeful it's...
Last Reply:
I understand Joanne. There are a million different ways to get thrown into the deep end of lung cancer and there's only so much understanding you can take in or find...
Last Reply:
I hope someone with experience will chime in. According to clinicians pleurex cath can be worn as long as it's functioning appropriately but at least several months.
Last Reply:
Janine, It's an interesting question. The schedule is one weekly drainage, and the doctor's order is not to drain any particular amount, but rather to drain however much fluid has accumulated...
Last Reply:
Hello, she just received the results from her "cancer track" liquid biopsy. She has been on tagrisso for 6 months now. EGFR mutation is not showing up, tp53 still present with...
Comments
_________________________________
Stage 4 ROS1+ [mucinous BAC] adenocarcinoma NSCLC since 2011
Xalkori (crizotinib) 5 yrs
Alimta (pemetrexed) + carboplatin (mere months)
TPX-0005 (repotrectinib) TBD (1+ years as of Fall 2018)